spacer
home > pmps > winter 2001 > bio/pharmos - a new forum for pharma and biotech contract manufacturing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Bio/PharMOS - A New Forum for Pharma and Biotech Contract Manufacturing

Seven weeks after the official launch of Bio/PharMOS, manufacturing professionals on both sides of the

customer-contractor equation no longer asked "Why Monte Carlo?" The event, due to take place between 26th and 28th March 2002 had become such an established item on the global agenda of forthcoming events that its host, VB International, was already making arrangements for the following year.

The Roll Out of Bio/PharMOS

VB International is an entirely independent group of contract manufacturing consultants who saw the need for a dedicated event for contract manufacturing services. After careful research, VB International launched Bio/PharMOS (Biotech & Pharma Manufacturing Outsource Services) in order to combine an exhibition and a conference for pharma and biotech outsourced manufacturing services with worldwide reach. This will be held in Monte Carlo next March. At the launch of Bio/PharMOS, Vanina Broens, CEO of the Monaco-based consulting group, saw "an unfulfilled need in this important manufacturing sector".


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Patricia Lobo, Editor of PMPS Reports Exclusively on a
Development in the International Manufacturing Business

spacer
Patricia Lobo
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its dual-terminal operations seamlessly

Completing the gradual transition process to Istanbul Airport, one of the largest airports of the world, the global air cargo brand Turkish Cargo maintains its dual-terminal operations with full capacity on 7/24 basis without any sales restriction.
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement